11,12 By 2029, total annual medical costs in the United States for people with hepatitis C are expected to more than double, from $30 billion in 2009 to approximately $85 billion.9 Special Note Regarding Forward-Looking Statements This press release contains forward-looking statements as ...
10.1002/hep.25606 [ Cross Ref ]D’Ambrosio R, Aghemo A, Rumi MG, Ronchi G, Donato MF, Paradis V, Colombo M, Bedossa P. A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis. Hepatology. 2012; 56...
Virahep-C Study Group. J Hepatol 2008; 49: 184–191. Genes and Immunity IL28B-associated SVR in Taiwanese chronic HCV infection J-Y Chen et al 45 Chen L, Sun J, Meng L, Heathcote J, Edwards AM, McGilvray ID. ISG15, a ubiquitin-like interferon-stimulated gene, pro- motes ...